Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (62)
  • 2024 (54)
  • 2023 (99)
  • 2022 (139)
  • 2021 (112)
  • 2020 (26)
  • 2019 (2)
  • 2018 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Major Law Enforcement Operation (267)
  • Diversion Division (242)

Drug Name

  • Fentanyl (145)
  • Cocaine (112)
  • Methamphetamine (87)
  • Heroin (76)
  • Opioids (52)
  • Oxycodone (39)
  • Synthetic Opioids (25)
  • Marijuana (Cannabis) (22)
  • Hydromorphone (13)
  • Benzodiazepines (7)
  • Morphine (7)
  • Amphetamines (3)
  • Ecstasy/MDMA (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana Concentrates (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • K2/Spice (1)
  • Ketamine (1)
  • LSD (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • Washington, DC (149)
  • New York (40)
  • New England (37)
  • Seattle (29)
  • El Paso (27)
  • New Jersey (23)
  • St. Louis (23)
  • Chicago (22)
  • Houston (21)
  • Sede (18)
  • San Francisco (16)
  • Atlanta (15)
  • Miami (15)
  • New Orleans (11)
  • Dallas (10)
  • San Diego (10)
  • Rocky Mountain (9)
  • Los Angeles (6)
  • Phoenix (6)
  • Omaha (4)
  • Louisville (3)
  • Detroit (1)
Clear All Results
PRESS RELEASE

Chemical Importer to Pay $300,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

Marzo 25, 2024
WACO, Texas – Shrieve Chemical Company, LLC, a Drug Enforcement Administration-registered importer and distributor of listed chemicals, has agreed to pay $300,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act, 21 U.S.C. §§ 801 et seq. In December 2022, DEA diversion investigators conducted...
Marzo 25, 2024
PRESS RELEASE

Nurse Practitioner Sentenced to 70 Months for Unlawful Drug Distribution

Marzo 01, 2024
ALBANY, NEW YORK – Danielle Simonson, age 52, of Fort Ann, New York, was sentenced today to 70 months in prison for distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...
Marzo 01, 2024
PRESS RELEASE

Two More Defendants Arrested During 2023 Joint Enforcement Operation in Carlsbad Plead Guilty to Federal Drug Offenses

Febrero 28, 2024
ALBUQUERQUE – Towanda R. Thorne-James, Special Agent in Charge of the Drug Enforcement Administration's El Paso Division, and Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Kassandra Lee Perales and Jared Michael Moore, two of the 12 defendants arrested during a joint enforcement...
Febrero 28, 2024
PRESS RELEASE

DEA Issues Letter to E-Commerce Companies on the Sale of Pill Presses Used to Make Fentanyl Pills

Febrero 26, 2024
WASHINGTON – The U.S. Drug Enforcement Administration today issued a letter to e-commerce companies regarding the sale of pill presses. As regulated entities under the Controlled Substances Act (CSA), e-commerce platforms are generally required to comply with CSA recordkeeping, identification, and reporting requirements on the distribution, importation, and exportation of...
Febrero 26, 2024
PRESS RELEASE

Co-Founder of Sinaloa Cartel Charged in Superseding Indictment with Conspiracy to Manufacture and Distribute Fentanyl

Febrero 15, 2024
BROOKLYN, N.Y. - A fifth superseding indictment was filed today in federal court in Brooklyn charging Ismael Zambada Garcia, also known as “El Mayo,” with conspiring to manufacture and distribute a substance, containing N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide (“fentanyl”), a Schedule II controlled substance intending and knowing that such substances would be unlawfully...
Febrero 15, 2024
PRESS RELEASE

Nurse Practitioner Arrested for Unlawful Drug Distribution

Febrero 09, 2024
ALBANY, NEW YORK – Christopher Viagrande, age 41, of Latham, New York, was arrested earlier this week and charged with distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. United States Attorney Carla B. Freedman and Special Agent in Charge Frank A. Tarentino III...
Febrero 09, 2024
PRESS RELEASE

Samson, Alabama Pharmacy Liable for $110,000 Penalty for Recordkeeping Violations of the Controlled Substances Act

Febrero 09, 2024
MONTGOMERY, Ala. -- Today, Acting United States Attorney Jonathan S. Ross announced that King Drug Co., Inc. (King Drug), a pharmacy previously doing business in Samson, Alabama, along with owner Traci Revels McCoy, is liable to the United States for $110,000 in civil monetary penalties after failing to comply with...
Febrero 09, 2024
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

Febrero 07, 2024
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
Febrero 07, 2024
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

Febrero 07, 2024
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
Febrero 07, 2024
PRESS RELEASE

eBay to Pay $59 Million to Settle Controlled Substances Act Allegations Related to Pill Presses Sold Through Its Website

Febrero 01, 2024
BURLINGTON, Vt. – eBay Inc, an e-commerce company headquartered in San Jose, California, has agreed to pay $59 million and to enhance its compliance program to resolve allegations that it violated the Controlled Substances Act (CSA) in connection with thousands of pill presses and encapsulating machines that were sold through...
Febrero 01, 2024
Showing 101 - 110 of 495 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 7
  • Página 8
  • Página 9
  • Página 10
  • Current page 11
  • Página 12
  • Página 13
  • Página 14
  • Página 15
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster